{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T21:40:23Z","timestamp":1683236423365},"reference-count":122,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1157\/13079075","type":"journal-article","created":{"date-parts":[[2005,9,30]],"date-time":"2005-09-30T10:18:25Z","timestamp":1128075505000},"page":"446-456","source":"Crossref","is-referenced-by-count":2,"title":["Inhibidores de la ciclooxigenasa-2 en la prevenci\u00f3n del c\u00e1ncer"],"prefix":"10.1016","volume":"205","author":[{"given":"J.J.","family":"Grau de Castro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13079075_bib1","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1517\/13543784.8.10.1623","article-title":"Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy","volume":"8","author":"Koki","year":"1999","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1157\/13079075_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1470-2045(01)00488-0","article-title":"Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer","volume":"2","author":"Danemberg","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1157\/13079075_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflamatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1157\/13079075_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ijc.1518","article-title":"Is COX-2 inhibition a panacea for cancer prevention?","volume":"94","author":"Vainio","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1157\/13079075_bib5","first-page":"138","article-title":"Quimioprevenci\u00f3n del c\u00e1ncer de mama","volume":"16","author":"Pic\u00f3 Navarro","year":"2002","journal-title":"Rev Cancer (Madrid)"},{"key":"10.1157\/13079075_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0025-7753(01)72243-9","article-title":"\u00c9tica de la actividad preventiva en Atenci\u00f3n Primaria","volume":"117","author":"Altisent","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13079075_bib7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0140-6736(77)92496-5","article-title":"Prostaglandins and breast cancer","volume":"2","author":"Bennett","year":"1977","journal-title":"Lancet"},{"key":"10.1157\/13079075_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3835(01)00715-7","article-title":"Selective inhibition of \u0394-6 desaturase impedes intestinal tumorigenesis","volume":"175","author":"Hansen-Petrik","year":"2002","journal-title":"Cancer Letters"},{"key":"10.1157\/13079075_bib9","doi-asserted-by":"crossref","first-page":"18563","DOI":"10.1074\/jbc.M010787200","article-title":"Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice","volume":"276","author":"Liu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1157\/13079075_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.onc.1202307","article-title":"Regulation of cyclooxygenase-2 pathway by HER2 receptor","volume":"18","author":"Vadlamudi","year":"1999","journal-title":"Oncogene"},{"key":"10.1157\/13079075_bib11","doi-asserted-by":"crossref","first-page":"18649","DOI":"10.1074\/jbc.M111415200","article-title":"Cyclooxygenase-2 is overexpressed in HER-2\/neu-positive breast cancer. Evidence for involvement of AP-1 and PEA3","volume":"277","author":"Subbaramaiah","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1157\/13079075_bib12","first-page":"5405","article-title":"Celecoxib, a selective Cyclooxygenase 2 inhibitor, protects against human epidermal factor receptor 2 (HER-2)\/neu-induced breast cancer","volume":"62","author":"Howe","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<295::AID-PATH254>3.0.CO;2-Y","article-title":"Early expression of cyclo-oxigenase-2 during sporadic colorectal carcinogenesis","volume":"187","author":"Hao","year":"1999","journal-title":"J Pathol"},{"key":"10.1157\/13079075_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/scbi.2001.0368","article-title":"Mouse models for human familial adenomatous polyposis","volume":"11","author":"Kucherlapati","year":"2001","journal-title":"Semmin Cancer Biol"},{"key":"10.1157\/13079075_bib15","first-page":"6846","article-title":"Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps","volume":"62","author":"Sonoshita","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/carcin\/23.8.1351","article-title":"The role of Cyclooxygenase-2 in two different morphological stages of intestinal polyps in APC D474 knockout mice","volume":"23","author":"Sunayama","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1157\/13079075_bib17","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.192323799","article-title":"Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis","volume":"99","author":"M\u00fcller-Decker","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1157\/13079075_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2744(199908)25:4<231::AID-MC1>3.0.CO;2-F","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis","volume":"25","author":"Fisher","year":"1999","journal-title":"Mol Carcinog"},{"key":"10.1157\/13079075_bib19","first-page":"293","article-title":"Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis","volume":"60","author":"Reddy","year":"2000","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/gut.48.5.660","article-title":"Non-steroidal anti-inflamatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a model by inducing apoptosis and inhibiting cell proliferation","volume":"48","author":"Brown","year":"2001","journal-title":"Gut"},{"key":"10.1157\/13079075_bib21","first-page":"3971","article-title":"Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer","volume":"7","author":"Yoshimatsu","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1157\/13079075_bib22","first-page":"6706","article-title":"Direct evidence for a role of cyclooxygenase 2-derived Prostaglandin E2 in human head and neck Xenograft tumors","volume":"62","author":"Zweifel","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib23","first-page":"403","article-title":"Prostaglandin E2 protects intestinal tumors from nonosteroidal anti-inflamatory drug-induced regression in Apc Min\/+ mice","volume":"62","author":"Hansen-Petrik","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib24","doi-asserted-by":"crossref","first-page":"15792","DOI":"10.1073\/pnas.95.26.15792","article-title":"Nuclear localization of prostaglandin E2 receptors","volume":"95","author":"Bhattacharya","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1157\/13079075_bib25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1073\/pnas.95.2.681","article-title":"Mechanisms underlying nonsteroidal antiinflamatory drug-mediated apoptosis","volume":"95","author":"Chan","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1157\/13079075_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00432-004-0567-6","article-title":"Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-(B as a possible target","volume":"130","author":"Kim","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1157\/13079075_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1157\/13043139","article-title":"Ciclooxigenasa 2 (COX-2), Helicobacter pylori y c\u00e1ncer g\u00e1strico","volume":"120","author":"Gisbert","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13079075_bib28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/92.23.1881","article-title":"Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements an anti-Helicobacter pylori therapy","volume":"92","author":"Correa","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1157\/13079075_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"key":"10.1157\/13079075_bib30","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.1074\/jbc.M211999200","article-title":"Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp-1 and Sp3-dependent activation of two proximal GC-rich promoter elements","volume":"278","author":"Sch\u00e4fer","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1157\/13079075_bib31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrc1046","article-title":"Radical causes of cancer","volume":"3","author":"Hussain","year":"2003","journal-title":"Nature Rev Cancer"},{"key":"10.1157\/13079075_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(98)00128-8","article-title":"Chemokines and their role in tumor growth and metastasis","volume":"220","author":"Wang","year":"1998","journal-title":"J Immunol Meth"},{"key":"10.1157\/13079075_bib33","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflamation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1157\/13079075_bib34","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0090-6980(02)00024-2","article-title":"Cyclooxygenase isozymes and their gene structures and expression","volume":"68-9","author":"Tanabe","year":"2002","journal-title":"Prostaglan & other Lipid Mediators"},{"key":"10.1157\/13079075_bib36","series-title":"COX-2 blockade in cancer prevention and therapy","first-page":"171","article-title":"Regulation of expression and potential carcinogenic role of cyclooxygenase-2","author":"Jang","year":"2003"},{"key":"10.1157\/13079075_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0304-3835(00)00604-2","article-title":"Inhibitory effects of 9-cis-retinoic acid and pyrrolidinedithiocarbamate on cyclooxygenase (COX)-2 expression and cell growth in human skin squamous carcinoma cells","volume":"161","author":"Kanekura","year":"2000","journal-title":"Cancer Letters"},{"key":"10.1157\/13079075_bib38","first-page":"3349","article-title":"Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxygenase-2","volume":"7","author":"Fujita","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1157\/13079075_bib39","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1158\/1078-0432.CCR-03-0677","article-title":"Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck","volume":"10","author":"Chen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1157\/13079075_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1054\/clnu.2002.0627","article-title":"The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes","volume":"22","author":"Llor","year":"2003","journal-title":"Clin Nutrition"},{"key":"10.1157\/13079075_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jcp.10068","article-title":"Many actions of cyclooxygenase-2 in cellular dynamics and in cancer","volume":"190","author":"Cao","year":"2002","journal-title":"J Cell Physiol"},{"key":"10.1157\/13079075_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1157\/13079075_bib43","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMra021902","article-title":"Rules for making human tumor cells","volume":"347","author":"Hahn","year":"2002","journal-title":"N Eng J Med"},{"key":"10.1157\/13079075_bib44","first-page":"356","article-title":"Effects of the cyclooxygenase inhibitor, Piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer","volume":"62","author":"Mohammed","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib45","first-page":"2443","article-title":"Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents","volume":"8","author":"Hida","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1157\/13079075_bib46","first-page":"586","article-title":"Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice","volume":"63","author":"Yao","year":"2003","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib47","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib48","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1053\/gast.2002.37053","article-title":"Nonsteroidal anti-inflamatory drugs, apoptosis, and colorectal adenomas","volume":"123","author":"Martin","year":"2002","journal-title":"Gastroenterol"},{"key":"10.1157\/13079075_bib49","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1157\/13079075_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0065-2571(00)00015-7","article-title":"Apoptosis signaling pathways mediated by Cyclooxygenase-2 inhibitors in prostate cancer cells","volume":"41","author":"Johnson","year":"2001","journal-title":"Advan Enzyme Regul"},{"key":"10.1157\/13079075_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3835(02)00003-4","article-title":"Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib","volume":"180","author":"Patti","year":"2002","journal-title":"Cancer Letters"},{"key":"10.1157\/13079075_bib52","first-page":"2029","article-title":"Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines","volume":"62","author":"Waskewitch","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","article-title":"Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoside synthase 2","volume":"83","author":"Tsujii","year":"1995","journal-title":"Cell"},{"key":"10.1157\/13079075_bib54","first-page":"2343","article-title":"Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer","volume":"62","author":"Kundu","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjc.6600462","article-title":"Cyclo-oxygenase inhibition reduces tumor growth and metastasis in an orthotopic model of breast cancer","volume":"87","author":"Connolly","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1157\/13079075_bib56","first-page":"1567","article-title":"Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis","volume":"62","author":"Kakiuchi","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib57","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/70995","article-title":"Inhibition of angiogenesis by nonsteroidal anti-inflamatory drugs: insight into mechanisms and implications for cancer growth an ulcer healing","volume":"5","author":"Jones","year":"1999","journal-title":"Nature Med"},{"key":"10.1157\/13079075_bib58","doi-asserted-by":"crossref","first-page":"23448","DOI":"10.1016\/S0021-9258(19)49483-0","article-title":"Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2","volume":"268","author":"Habib","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1157\/13079075_bib59","doi-asserted-by":"crossref","first-page":"29260","DOI":"10.1074\/jbc.M203996200","article-title":"Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice","volume":"277","author":"Matsumoto","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1157\/13079075_bib60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"10.1157\/13079075_bib61","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2174\/0929867003374336","article-title":"Role of cyclooxygenases in angiogenesis","volume":"7","author":"Leahy","year":"2000","journal-title":"Current Med Chem"},{"key":"10.1157\/13079075_bib62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20021408","article-title":"Host prostaglandin E2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth","volume":"197","author":"Amano","year":"2003","journal-title":"J Exp Med"},{"key":"10.1157\/13079075_bib63","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI9621","article-title":"Host cyclooxygenase-2 modulates carcinoma growth","volume":"105","author":"Williams","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1157\/13079075_bib64","first-page":"625","article-title":"Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo","volume":"62","author":"Leahy","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib65","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bjp.0703327","article-title":"Ciclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants","volume":"130","author":"Majima","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1157\/13079075_bib66","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1054\/bjoc.2001.1809","article-title":"3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon","volume":"84","author":"Konerding","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1157\/13079075_bib67","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1210\/jc.87.7.3504","article-title":"Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells","volume":"87","author":"Tamura","year":"2002","journal-title":"J Clin Endoc Metab"},{"key":"10.1157\/13079075_bib68","first-page":"6045","article-title":"Celecoxib prevents tumor growth in Vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models","volume":"60","author":"Williams","year":"2000","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib69","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1006\/cyto.1999.0622","article-title":"Interferon-g and interleukin 4 inhibit interleukin 1b-induced delayed prostaglandin E2 generation throughout suppression of cyclooxigenase-2 expression in human fibroblasts","volume":"12","author":"Hayashi","year":"2000","journal-title":"Cytokine"},{"key":"10.1157\/13079075_bib70","first-page":"7042","article-title":"Vascular endothelial growth factor secretion by tumor-infiltrating macrofagues essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process","volume":"62","author":"Barbera-Guill\u00e9n","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.neo.7900054","article-title":"Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by antitumor antibodies","volume":"1","author":"Barbera-Guill\u00e9n","year":"1999","journal-title":"Neoplasia"},{"key":"10.1157\/13079075_bib72","first-page":"729","article-title":"Upregulation of tumor interleukin-8 expression by infiltrating macrophagages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer","volume":"9","author":"Chen","year":"2003","journal-title":"Clin Can Res"},{"key":"10.1157\/13079075_bib73","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/annonc\/mdf125","article-title":"Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer Chemoprevention","volume":"13","author":"Davies","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1157\/13079075_bib74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/cyto.1999.0562","article-title":"An antibody for macrophage migration inhibitory factor suppresses tumor growth and inhibits tumor-associated angiogenesis","volume":"12","author":"Ogawa","year":"2000","journal-title":"Cytokine"},{"key":"10.1157\/13079075_bib75","first-page":"3282","article-title":"Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer","volume":"6","author":"Ueno","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1157\/13079075_bib76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4049\/jimmunol.163.1.111","article-title":"Induction of cyclooxygense-2 on activated T lymphocytes: regulation of T Cell activation by cyclooxygenase-2 inhibitors","volume":"163","author":"I\u00f1iguez","year":"1999","journal-title":"J Immunol"},{"key":"10.1157\/13079075_bib77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.164.1.361","article-title":"Specific inhibition of cyclooxygenase-2 restores antitumor reactivity by altering the balance of OL-10 and IL-12 synthesis","volume":"164","author":"Stolina","year":"2000","journal-title":"J Immunol"},{"key":"10.1157\/13079075_bib78","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4049\/jimmunol.168.5.2255","article-title":"Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, wich down-regulates dendritic cell functions","volume":"168","author":"Harizi","year":"2002","journal-title":"J Immunol"},{"key":"10.1157\/13079075_bib79","first-page":"961","article-title":"Tumor cyclooxygenase 2-dependent suppression of dendritic cell function","volume":"9","author":"Sharma","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1157\/13079075_bib80","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib81","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"Sandler","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib82","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","article-title":"Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis","volume":"328","author":"Giardello","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib83","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cycloxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib84","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/gut.50.6.857","article-title":"A randomized, double blind, placebo controlled study of Celecoxib, a selective cycloxigenase-2 inhibitor, on duodenal polyposis in familial adenomatous polyposis","volume":"50","author":"Phillips","year":"2002","journal-title":"Gut"},{"key":"10.1157\/13079075_bib85","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1054\/bjoc.2000.1709","article-title":"Breast cancer and NSAID use: a meta-analysis","volume":"84","author":"Khuder","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1157\/13079075_bib86","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/cncr.11242","article-title":"Risk of lung carcinoma among users of nonsteroidal antiinflamatory drugs","volume":"97","author":"Muscat","year":"2003","journal-title":"Cancer"},{"key":"10.1157\/13079075_bib87","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1054\/bjoc.1999.1106","article-title":"Non-steroidal anti-inflamatory drugs and bladder cancer prevention","volume":"82","author":"Castelao","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1157\/13079075_bib88","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.bjc.6600820","article-title":"Aspirin use and cancer of the upper aerodigestive tract","volume":"88","author":"Bosseti","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1157\/13079075_bib89","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/jnci\/94.15.1168","article-title":"Association between nonsteroidal anti-inflamatory drug use and the incidence of pancreatic cancer","volume":"94","author":"Anderson","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1157\/13079075_bib90","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","article-title":"Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk","volume":"291","author":"Terry","year":"2004","journal-title":"JAMA"},{"key":"10.1157\/13079075_bib91","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bjc.6602003","article-title":"Risk of breast cancer among users of aspirin and other anti-inflammatory drugs","volume":"91","author":"Garc\u00eda-Rodr\u00edguez","year":"2004","journal-title":"Brit J Cancer"},{"key":"10.1157\/13079075_bib92","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1055-9965.649.13.4","article-title":"Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer","volume":"13","author":"Garc\u00eda-Rodr\u00edguez","year":"2004","journal-title":"Cancer Epidemiol Biomarkers & Prev"},{"key":"10.1157\/13079075_bib93","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2003.07.127","article-title":"Celecoxib, a selective cyclo-oxigenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer","volume":"21","author":"Altorki","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1157\/13079075_bib94","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B","article-title":"COX-2 is expressed in human pulmonary, colonic, and mammary tumors","volume":"89","author":"Soslow","year":"2000","journal-title":"Cancer"},{"key":"10.1157\/13079075_bib95","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1158\/1078-0432.CCR-03-0354","article-title":"Prognostic significance of cyclooxygenase-2 in oropharyngeal squamous cell carcinoma","volume":"10","author":"Chang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1157\/13079075_bib96","first-page":"632","article-title":"Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer","volume":"62","author":"Ristim\u00e4ki","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13079075_bib97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","article-title":"Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US. Preventive Services Task Force","volume":"136","author":"Hayden","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1157\/13079075_bib98","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/00912700022008766","article-title":"Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial","volume":"40","author":"Leese","year":"2000","journal-title":"J Clin Pharmacol"},{"issue":"Supl 3","key":"10.1157\/13079075_bib99","first-page":"46","article-title":"Impacto econ\u00f3mico de los efectos secundarios gastrointestinales asociados a antiinflamatorios no esteroideos en el Servicio Nacional de Salud","volume":"114","author":"Lanas","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13079075_bib100","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of Rofecoxib and Naproxen in patients with rheumatoid artritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib101","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonesteroidal anti-inflamatorydrugs for osteoarthritis and reumathoid arthritis: the CLASS study: a randomized study. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1157\/13079075_bib102","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/bmj.325.7365.619","article-title":"Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthitis: systematic review of randomised controlled trials","volume":"325","author":"Deeks","year":"2002","journal-title":"Br Med J"},{"key":"10.1157\/13079075_bib103","doi-asserted-by":"crossref","first-page":"12400","DOI":"10.1073\/pnas.240459597","article-title":"Anti-inflamatories for cardiovascular disease","volume":"97","author":"Masferrer","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1157\/13079075_bib104","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(04)16299-5","article-title":"Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study","volume":"363","author":"Mamdani","year":"2004","journal-title":"Lancet"},{"key":"10.1157\/13079075_bib105","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.0000127578.21885.3E","article-title":"Relationship between selective cyclooxygenase inhibitors and acute myocardial infarction in older adults","volume":"109","author":"Solomon","year":"2004","journal-title":"Circulation"},{"key":"10.1157\/13079075_bib106","first-page":"95","article-title":"Cyclooxigenase-2 inhibition for the treatment of cervical intraepithelial neoplasia [abstract 381]","volume":"22","author":"Miller","year":"2003","journal-title":"Proceed Am Soc Clin Oncol"},{"key":"10.1157\/13079075_bib107","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.bjc.6600829","article-title":"Nonsteroidal anti-inflamatory drugs in colorectal cancer: from prevention to therapy","volume":"88","author":"Ricchi","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1157\/13079075_bib108","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/annonc\/mdh051","article-title":"Chemoprevention of lung cancer-from biology to clinical reality","volume":"15","author":"Winerhalter","year":"2004","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"10.1157\/13079075_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.seminoncol.2003.12.014","article-title":"Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small lung cancer","author":"Komaki","year":"2004","journal-title":"Sem Oncol"},{"key":"10.1157\/13079075_bib110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00042307-200405000-00002","article-title":"Update on chemoprevention of prostate cancer","volume":"14","author":"Klein","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1157\/13079075_bib111","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/0008-5472.CAN-03-2188","article-title":"Cyclooxygenase-2 is essential for HER\/neu to suppress N-(hydroxyphenyl) retinamide apoptotic effects in breast cancer cells","volume":"64","author":"Simone","year":"2004","journal-title":"Cancer Res"},{"issue":"Suppl 3","key":"10.1157\/13079075_bib112","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.seminoncol.2004.01.008","article-title":"Cyclooxygenase-2: a potential target in breast cancer","volume":"1","author":"Wang","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1157\/13079075_bib113","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/sj.onc.1207295","article-title":"Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2","volume":"23","author":"Benoit","year":"2004","journal-title":"Oncogene"},{"key":"10.1157\/13079075_bib114","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1470-2045(03)01220-8","article-title":"Inhibitors of cyclooxygenase 2: a new class of anticancer agents?","volume":"4","author":"Gasparini","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1157\/13079075_bib115","first-page":"2061","article-title":"Expression of cyclooxygenase-2 mRNA (COX2-mRNA) in peripheral blood of head and neck cancer patients and healthy controls [abstract]","volume":"23","author":"Grau","year":"2004","journal-title":"Proc ASCO"},{"key":"10.1157\/13079075_bib116","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1464-410X.2004.04601.x","article-title":"A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy","volume":"3","author":"Pruthi","year":"2004","journal-title":"BJU Int"},{"key":"10.1157\/13079075_bib117","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/jnci\/djg058","article-title":"Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rationale advance?","volume":"95","author":"Choi","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1157\/13079075_bib118","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib119","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib120","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","article-title":"Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery","volume":"352","author":"Nussmeier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib121","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMe058042","article-title":"COX-2 inhibitors-lessons in drug safety","volume":"352","author":"Psaty","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1157\/13079075_bib122","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMp058055","article-title":"Raising the safety bar - The FDA's Coxib Meeting","volume":"352","author":"Okie","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256505726072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256505726072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T20:58:37Z","timestamp":1683233917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256505726072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":122,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0014256505726072"],"URL":"https:\/\/doi.org\/10.1157\/13079075","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}